LD 02GIFRO
Alternative Names: LD02GIFROLatest Information Update: 27 Sep 2021
Price :
$50 *
At a glance
- Originator LG Life Sciences
- Developer LG Chem; LG Life Sciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Postoperative ileus
Most Recent Events
- 27 Sep 2021 Discontinued - Phase-II for Postoperative ileus in South Korea (LG Chem website, September 2021)
- 27 Sep 2021 Discontinued - Preclinical for Postoperative ileus in China (LG Chem website, September 2021)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Postoperative-ileus in China